0

524516

BACPHAR

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

BACIL PHARMA LTD. Share Price Today

Investment Returns

Over 1 Month -17.79% Over 3 Months -6.12% Over 6 Months 16.63% Over 1 Year 26.14%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

BACIL PHARMA LTD. fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 68.90
  • P/E Ratio (TTM) 44.01
  • Beta 0.66
  • Book Value / share 17.55
  • Return on equity -0.98%
  • EPS (TTM) 1.08
  • Dividend yield [-]%
  • Net profit/quarter (Cr) 0.62
info icon alternate text

BACIL PHARMA LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars MAR 2026 (Values in Cr)
Revenue 0.00
Operating Expense 0.07
Net Profit 0.62
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.44
EBITDA 0.04
Effective Tax Rate (%) -1449.99
Particulars DEC 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.03
Net Profit 0.04
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.03
EBITDA 0.04
Effective Tax Rate (%) 0.00
Particulars SEP 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.04
Net Profit 0.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.01
EBITDA 0.02
Effective Tax Rate (%) 0.00
Particulars JUN 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.11
Net Profit 0.67
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.48
EBITDA 0.89
Effective Tax Rate (%) 24.71
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.07
Net Profit 0.02
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.03
EBITDA 0.02
Effective Tax Rate (%) 0.00
Particulars MAR 2026 (Values in Cr)
Revenue 0.00
Operating Expense 0.25
Net Profit 1.56
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 1.11
EBITDA 0.99
Effective Tax Rate (%) -57.57
Particulars MAR 2025 (Values in Cr)
Revenue 0.00
Operating Expense 0.25
Net Profit 0.40
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.69
EBITDA 0.41
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.19
Net Profit -0.06
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.10
EBITDA -0.06
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 0.22
Net Profit -0.10
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.17
EBITDA -0.10
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 3.92
Net Profit -3.86
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -6.55
EBITDA -3.86
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 18.20
ROE % -0.98
ROCE % -1.04
Total Debt to Total Equity 0.01
EBITDA Margin 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1.86
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.05
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1.68
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.02
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share 1.88
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.08
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 2.13
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.13
EBITDA Margin 0.00
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 2.85
Total Assets 25.60
Total Liabilities 25.60
Total Equity 25.43
Share Outstanding 1
Price to Book Ratio 2.33
Return on Assets (%) 1.57
Return on Capital (%) 1.58
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 1.32
Total Liabilities 1.32
Total Equity 1.21
Share Outstanding 0
Price to Book Ratio 7.87
Return on Assets (%) -4.45
Return on Capital (%) -4.5
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 1.12
Total Liabilities 1.12
Total Equity 1.09
Share Outstanding 0
Price to Book Ratio 3.26
Return on Assets (%) -9.03
Return on Capital (%) -9.1
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.22
Total Assets 1.27
Total Liabilities 1.27
Total Equity 1.22
Share Outstanding 0
Price to Book Ratio 3.05
Return on Assets (%) -303.54
Return on Capital (%) -306.94
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 4.08
Total Liabilities 4.08
Total Equity 1.39
Share Outstanding 0
Price to Book Ratio 1.46
Return on Assets (%) -5.85
Return on Capital (%) -15.27
Particulars MAR 2025 (Values in Cr)
Net Income 0.40
Cash from Operations 0.40
Cash from Investing 0.33
Cash from Financing 2.07
Net change in Cash 2.81
Free Cash Flow 0.40
Particulars MAR 2024 (Values in Cr)
Net Income -0.05
Cash from Operations 0.00
Cash from Investing 0.07
Cash from Financing -0.06
Net change in Cash 0.01
Free Cash Flow 0.00
Particulars MAR 2023 (Values in Cr)
Net Income -0.10
Cash from Operations -0.14
Cash from Investing -0.11
Cash from Financing 0.06
Net change in Cash -0.20
Free Cash Flow -0.14
Particulars MAR 2022 (Values in Cr)
Net Income -3.86
Cash from Operations -4.00
Cash from Investing 3.81
Cash from Financing 0.32
Net change in Cash 0.13
Free Cash Flow -4.00
Particulars MAR 2021 (Values in Cr)
Net Income -0.23
Cash from Operations -0.39
Cash from Investing 0.52
Cash from Financing -0.07
Net change in Cash 0.05
Free Cash Flow -0.39
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 33.07 13.67 1.60 253.43 23.12 38.85
BLISS GVS PHARMA LTD 423.70 34.28 3.75 4482.28 118.35 462.70
CIPLA LTD. 1376.25 29.21 3.22 111179.71 1165.55 1672.20
FERMENTA BIOTECH LTD. 327.50 14.45 2.37 963.86 256.40 399.00
GLAXOSMITHKLINE PHARMA LT 2174.30 38.28 16.24 36833.95 2136.05 3500.00
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENTERPRISES L 33.07 23.13 4.26 253.43 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 568.05 25.46 4.43 1642.27 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8304.35 108.45 23.78 20760.88 7630.00 10653.05
BLISS GVS PHARMA LTD 423.70 45.56 3.88 4482.28 118.35 462.70

BACIL PHARMA LTD. shareholding pattern

Holding
100.0%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

BACIL PHARMA LTD. Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
48.03 1.05 redarrow
red-green-graph indicator
14 Bearish
2 Bullish
  • 5 Days 49.50
  • 26 Days 52.10
  • 10 Days 50.20
  • 50 Days 52.10
  • 12 Days 50.50
  • 100 Days 49.90
  • 20 Days 51.60
  • 200 Days 45.70
49.76 PIVOT
First Support 44.53 First Resistance 52.77 Second Support 41.52 Second Resistance 58.00 Third Support 36.29 Third Resistance 61.01
RSI 37.82 ADX 12.63 MACD -1.52 Williams % R -91.15 Commodity Channel Index (CCI) -76.39
Date 2026-06-10 Week 234460.00 Same Day 927620.00 Month 67036.00
1 Year 0.67 3 Year 0.08
Over 1 Month
-17.79% down
Over 1 Year
26.14% down
Over 3 Months
-6.12% down
Over 3 Years
72.12% down
Over 6 Months
16.63% down
Over 5 Years
45.25% down

BACIL PHARMA LTD. Corporate Actions

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Bacil Pharma Ltd?

Answer Field

Bacil Pharma Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 48.03 as on Jun 11 2026 03:28 PM.

What is the Market Cap of Bacil Pharma Ltd Share?

Answer Field

The market cap of Bacil Pharma Ltd for NSE ₹ 0.00 & for BSE ₹ 68.90 as on Jun 11 2026 03:28 PM.

What is the 52 Week High and Low of Bacil Pharma Ltd?

Answer Field

The 52 Week High and Low of Bacil Pharma Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 61.80 and ₹ 26.69.

What is 1 year return for Bacil Pharma Ltd?

Answer Field

The 1 year returns on the stock has been 26.14%.

What is the P/E Ratio of Bacil Pharma Ltd Share?

Answer Field

As on Jun 11 2026 03:28 PM the price-to-earnings (PE) ratio for Bacil Pharma Ltd share is 44.01.

What is the PB ratio of Bacil Pharma Ltd Share?

Answer Field

As on Jun 11 2026 03:28 PM, the price-to-book (PB) ratio for Bacil Pharma Ltd share is 17.55.

How to Buy Bacil Pharma Ltd Share?

Answer Field

You can trade in Bacil Pharma Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Bacil Pharma Ltd Share on Bajaj Broking App?

Answer Field

To buy Bacil Pharma Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Bacil Pharma Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|